Outpace Bio logo

Outpace Bio

outpacebio.com

Outpace Bio develops AI-powered protein design technologies to create engineered cell therapies for cancer treatment. Its platform programs cells to improve potency, specificity, persistence, and safety, aiming to make cell therapies effective, safe, and scalable across diverse cancer indications. The organization’s mission is to cure cancer by overcoming biological barriers through advanced cellular engineering.

Facts

HQ
Seattle, Washington, US
Sectors
Biotechnology Research
Founded
2020
Type
Corporation Seattle business license
Employees
74
Registered name
Outpace Bio Inc Seattle business license
Stage
Series A
Members see funding amounts.
.

Is this your organization? Claim it

Fred Hutch-Led Synthesize Bio Raises $10M to Accelerate Drug Discovery Using AI Gene Expression Model

Seattle-based Synthesize Bio, led by Fred Hutchinson Cancer Center researchers, raised $10 million from Madrona to accelerate drug discovery using their AI model GEM-1, which predicts gene expression outcomes with lab-level accuracy. The startup aims to reduce drug development time and costs by simulating hypothetical lab experiments with generative genomics.

See all 7 stories, episodes and videos about Outpace Bio.

People

See all 5
  • Marc Lajoie
    Marc Lajoie Executive Officer, Director, Promoter, Co-founder & Chief Executive Officer
  • Scott Boyken Executive Officer, Director, Promoter, Co-founder & Chief Innovation Officer
  • Aaron Foster Executive, Executive Officer, Chief Scientific Officer

Online